Methylene Chloride

Methylene Chloride

SCHEMBL8030727

CS(=O)(=O)O.ClCCl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol

The experimentally established mechanism targets of Methylene Chloride. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methylene Chloride SCHEMBL28193861 0.96
Methylene Chloride SCHEMBL8949658 0.96 CA2 (0.41)
Sulfuric Acid SCHEMBL6247161 0.82
SCHEMBL246838 0.82 CA2 (0.58)
SCHEMBL8596055 0.82 CA2 (0.58)
SCHEMBL128169 0.82
SCHEMBL15109974 0.82
SCHEMBL25599 0.82 CA2 (0.58)
SCHEMBL105 0.82
Methylene Chloride SCHEMBL9185705 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023134465-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR, INTERMEDIATE THEREOF AND USE THEREOF 上海艾力斯医药科技股份有限公司 2023-07-20 WO disclosed
EP-3388425-B1 AMINOAZOLE DERIVATIVE TEIJIN PHARMA LTD (JP) 2020-08-05 EP disclosed
US-10689354-B2 Aminoazole derivative TEIJIN PHARMA LIMITED (JP) 2020-06-23 US disclosed
US-20190031628-A1 AMINOAZOLE DERIVATIVE TEIJIN PHARMA LIMITED (JP) 2019-01-31 US disclosed
EP-3388425-A1 AMINOAZOLE DERIVATIVE Teijin Pharma Limited (JP) 2018-10-17 EP disclosed
CN-104262290-B Preparation method of pridinol mesylate 湖北工业大学 2017-01-11 CN disclosed
WO-2015085482-A1 EGFR INHIBITOR FORMS NOVARTIS AG (CH) 2015-06-18 WO disclosed
WO-2015083059-A1 FORMS OF THE EGFR INHIBITOR NOVARTIS AG (CH) 2015-06-11 WO disclosed
WO-2015081463-A1 EGFR INHIBITOR FORMS NOVARTIS AG (CH) 2015-06-11 WO disclosed
CN-104262290-A Preparation method of pridinol mesylate UNIV HUBEI TECHNOLOGY 2015-01-07 CN disclosed
CN-1127502-C Paroxetine methanesulfonate SMITHKLINE BEECHAM PLC (GB) 2003-11-12 CN disclosed
CN-1315949-A Salts of paroxetine SMITHKLINE BEECHAM PLC (GB) 2001-10-03 CN disclosed
US-6043387-A USEFUL AS KEY COMPONENTS IN CATALYSTS FOR ASYMMETRIC REACTIONS, PROVIDING DESIRABLY HIGH ENANTIOMERIC EXCESS MERCK & CO., INC. (US) 2000-03-28 US disclosed
CN-1182086-A New bisimide compounds, process for preparing them and pharmaceutical compositions containing them ADIR (FR) 1998-05-20 CN disclosed
EP-0125053-B1 PROCESS FOR PREPARING SECONDARY AMINES SMITHKLINE BECKMAN CORPORATION (US) 1986-09-17 EP disclosed
US-4579972-A Intermediates for preparing secondary amines SMITHKLINE BECKMAN CORPORATION (US) 1986-04-01 US disclosed
US-4540819-A Process for preparing secondary amines SMITHKLINE BECKMAN CORPORATION (US) 1985-09-10 US disclosed
EP-0125053-A1 Process for preparing secondary amines SMITHKLINE BECKMAN CORPORATION (US) 1984-11-14 EP disclosed
US-4426311-A Methylene chloride-methane sulfonic acid stripping compositions and methods for using same ALLIED CORPORATION (US) 1984-01-17 US disclosed
EP-0043438-A2 Methylene chloride-methane sulfonic acid stripping compositions and methods for using same ALLIED CORPORATION (US) 1982-01-13 EP disclosed